For an optimal user experience, this site uses cookies. By continuing to browse this site, you accept the usage of cookies. Learn More.

  1. Home
  2. All projects
Closed operation
PEA PEA-PME IR
NH TherAguix 1,000,000 € NH TherAguix is a pharmaceutical company developing innovative nanomedicine that improves the benefits of radiotherapy without modifying current clinical methods. AGuIX® protected by 4 international patents, is currently in phase 1 on the treatment of brain metastases.
View the company record
Closed operation
IR

Crosstalent

3,000,000 €

Crosstalent is a French editor that markets Cloud and SaaS software for HR and talent management.

Closed operation
ISF PEA PEA-PME IR

Medsteer

2,000,000 €

Medsteer develops a device that reduces post-operative disorders by regulating real-time anesthesia during an operation. By relying on the patient's brain activity, the device avoids periods of deep sleep which cause many side effects.

Closed operation
PEA PEA-PME IR

AlzProtect

14,000,000 €

AlzProtect is developing AZP2006, a major step forward in the treatment of the Alzheimer's disease, and by extension, in the treatment of neurodegenerative diseases. The product AlzProtect, protected by four families of patents, is entering into the phase 1b.

Closed operation
ISF PEA PEA-PME IR

InnaVirVAx

2,000,000 €

InnaVirVax develops a therapeutic vaccine against HIV, allowing for patients’ functional cure or remission. Phase I/IIa results have showed in 2015 a significant decrease of the “viral reserve”.

Closed operation
PEA PEA-PME

boostHEAT

4,000,000 €

boostHeat has developed a boiler that divides by two energy consumption and environmental footprint, compared to the best current condensing boilers.

Legal notices by vingtcinq
FR | EN